Quantitative Determination of AZD3264, a Selective IkB-kinase IKK2 Inhibitor, in Dog Plasma by Solvent Induced Phase Transition Extraction Coupled with HPLC-MS/MS and its Application to Pharmacokinetic Study in Dogs,Journal of AOAC INTERNATIONAL

当前位置： X-MOL 学术 › J. AOAC Int. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Quantitative Determination of AZD3264, a Selective IkB-kinase IKK2 Inhibitor, in Dog Plasma by Solvent Induced Phase Transition Extraction Coupled with HPLC-MS/MS and its Application to Pharmacokinetic Study in Dogs
Journal of AOAC INTERNATIONAL ( IF 1.6 ) Pub Date : 2020-09-30 , DOI: 10.1093/jaoacint/qsaa134
Gang Li ₁ , Shuofu Liang ₂ , Kesen Qiao ₁ , Chao Wang ₁

Affiliation

AZD3264 is a small molecule inhibitor of selective IkB-kinase IKK2 currently in preclinical development for the potential treatment of asthma and COPD.

中文翻译：